tiprankstipranks
Trending News
More News >
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
12Bullish
5Neutral
5Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Buy
8Bullish
0Neutral
4Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.19, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 21.68, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 21.27, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Oct 19, 2025, 10:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.98
21.69
21.98
21.69
21.98
21.69
21.98
Fibonacci
21.69
21.69
21.69
21.69
21.69
21.69
21.69

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Oct 19, 2025, 10:23 AM
Period
Simple
Exponential
MA5
21.80Sell
21.86Sell
MA10
21.88Sell
21.81Sell
MA20
21.64Buy
21.68Buy
MA50
21.28Buy
21.27Buy
MA100
20.61Buy
20.71Buy
MA200
19.74Buy
20.13Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 21.81, making it a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 20.71, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 21.28, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 20.61, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 19.74, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Oct 19, 2025, 10:23 AM
Name
Value
Action
RSI (14)
51.80
Neutral
STOCH (9,6)
68.02
Neutral
STOCHRSI (14)
76.19
Neutral
MACD (12,26)
0.19
Buy
ADX (14)
17.93
Buy
Williams %R
-51.01
Buy
CCI (14)
18.58
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
56.17
Neutral
ROC
2.60
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 51.80, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 17.93, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 18.58, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 2.60, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 51.80, which suggests CURE is a Neutral.
      What is CURE’s MACD?
      CURE’s MACD is 0.19, which suggests CURE is a Buy.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 21.80, which suggests CURE is a Sell.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 21.64, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 21.28, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 19.74, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -51.01, which suggests CURE is a Buy.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 18.58, which suggests CURE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement